Rays Power Infra announced closure of INR 127 Crore Equity Capital Fund Raise - INDIA’S FIRST ALL-WOMEN SUPERCAR COMMUNITY, QUEENS DRIVE CLUB, MAKES MUMBAI DEBUT WITH A DRIVE FOR CANCER AWARENESS - Rentomojo Limited Announced it's Initial Public Offer (IPO) to open on Wednesday, September 09, 2026 Price Band has been fixed at ₹ 384 to ₹ 404 per Equity Share - Manipal Payment and Identity Solutions Limited Announced its Initial Public Offering (IPO) to Open on Wednesday, September 9, 2026 Price Band fixed at ₹322 to ₹339 per equity share of face value of ₹10 each - LCC Projects fixes IPO price band at Rs 139-146 per share; issue opens on Sep 9 - KARAMTARA ENGINEERING LIMITED ANNOUNCED ITS INITIAL PUBLIC OFFERING (IPO) OF EQUITY SHARES TO OPEN ON WEDNESDAY 09 SEPTEMBER 2026 Price Band fixed at ₹241 to ₹254 per equity share of face value of ₹10 each - LCC Projects Limited announces the price band for its IPO - Ola Electric's First Dealer Stores are Now Open across India - Prasol Chemicals Limited Announced its initial Public Offering (IPO) to Open on September 8 at Price Band of ₹643–₹676 - Asset Reconstruction Company (India) Limited Announced it's Initial Public Offering (IPO) to open on Wednesday, September 09, 2026 The Price Band of the Offer has been fixed from ₹ 132 per Equity Share of face value ₹ 10 each to ₹139per Equity Share of face value of ₹ 10 each - Veegaland Developers Limited’s IPO to Open on Thursday, September 10, 2026 Price Band fixed at ₹130 to ₹140 per equity share of face value of ₹10 each

BeatO partners with Saksham to assist 100 children manage their Type 1 diabetes

–          Deploys BeatO’s IoT devices along with unlimited access to testing strips and other consumables

–          Provides technology dashboard to Saksham’s diabetes educator to proactively intervene based on the childrens’ sugar readings

–           

MUMBAI, September 9, 2020 (GNI): Digital health platform for diabetes management, BeatO today announced its collaboration with Saksham, a charitable trust which assists individuals with Type 1 Diabetes thereby providing them with regular information, motivation and support for diabetes management. 

BeatO is collaborating with Saksham to adopt 100 children with Type 1 diabetes by the end of FY’21. BeatO will assist children with diabetes management tools to be able to control their blood-sugar levels more efficiently. These tools include complimentary access to BeatO’s smartphone glucometer and feature-rich BeatO app. BeatO will also provide its technology dashboard to Saksham’s diabetes educators to timely manage and proactively intervene based on the children’s sugar readings taken through HealthNeuronTM, BeatO’s AI triaging system. Further, BeatO is also educating their parents on effectively helping their children manage Type 1 diabetes.

Incepted under the guidance of Endocrinologist Dr. Beena Bansal (Ex-Director of Division of Endocrinology, Medanta), Saksham’s support team educates and enables individuals with Type 1 diabetes, as well as their caregivers to face life challenges with strength and intellect.

Given the social stigma associated with diabetes, especially in young children, this support will help the children manage their condition better, and hence respond to social situations and their environment more effectively.

Commenting on this partnership, Gautam Chopra, Co-Founder & CEO, BeatO said, “Type 1 Diabetes can be difficult for children to manage, but it does not have to be. Through this partnership we are looking forward to empowering children to manage their sugar levels easily with BeatO’s connected devices and app and getting expert support when they need it the most. This will not only instil confidence in them that someone is there to help, but also give them freedom from the stress of daily decision making,”

This partnership aims to extend technological support for self-management of diabetes, a chronic condition which requires constant commitment and care by the patient and their caretakers equally, stated in the press release.

Through BeatO’s HealthNeuronTM system, BeatO is able to monitor people with Diabetes real time, and provide timely triggers for proactive intervention through specialists as soon as the system senses a need for this intervention. A recent research study by  BeatO on the effects of counselling by diabetes educators showed a significant improvement of 9.45% on fasting sugar levels and PP levels along with a large number of users being able to shift their sugar reading range to safe, normal range. In addition, a sharp reduction in Hypoglycemia episodes was seen and this is extremely relevant for people with Type 1 Diabetes.ends

Be the first to comment on "BeatO partners with Saksham to assist 100 children manage their Type 1 diabetes"

Leave a comment

Your email address will not be published.


*